SCA
NERV icon

Secor Capital Advisors’s Minerva Neurosciences NERV Stock Holding History

Secor Capital Advisors’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,456
Closed -$89K – 559
2017
Q3 		$89K Buy
+1,456
New +$83.5K 0.01% 421
2017
Q2 		– Sell
-2,254
Closed -$146K – 542
2017
Q1 		$146K Buy
+2,254
New +$175K 0.02% 445

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Secor Capital Advisors's NERV Position: Q4 2017 in Review

Secor Capital Advisors sold out of Minerva Neurosciences (NERV) in Q4 2017, closing a stake of 1,456 shares — an estimated $89K sold.

Secor Capital Advisors first reported a position in NERV in Q1 2017 and held it in 2 quarters. The position peaked at $146K in Q1 2017. 67 funds tracked by Wall St. Rank hold NERV as of Q4 2017.

  • Secor Capital Advisors reported no remaining Minerva Neurosciences position as of Q4 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 1,456 Minerva Neurosciences shares in Q4 2017, an estimated $89K.
  • Secor Capital Advisors first reported a position in Minerva Neurosciences in Q1 2017 and held it in 2 quarters.
  • Secor Capital Advisors's Minerva Neurosciences position peaked at $146K in Q1 2017.
  • 67 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2017.

Based on Secor Capital Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.